Search results
Public Employees Retirement Association of Colorado Grows Holdings in Teva Pharmaceutical Industries...
ETF DAILY NEWS· 1 day agoPublic Employees Retirement Association of Colorado increased its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA
TEVA Stock Rises 135% in a Year: What's Driving the Recovery?
Zacks· 6 days agoTeva Pharmaceutical Industries Limited’s (TEVA Quick QuoteTEVA - Free Report) revenues have suffered...
Baltimore reaches $45M settlement with pharmaceutical company over its role in opioid epedimic
CBS News· 2 hours agoThe City of Baltimore struck a $45 million deal with pharmaceutical giant Allergan in a lawsuit over...
JD Supra: Federal Circuit Review
JD Supra· 19 hours agoIn Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals Usa, Inc., Appeal No. 22-1258, the Federal Circuit held that district court ...
Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Insider Weiss Amir sells 12,635 Shares – Knox Daily
Knox Daily· 5 days agoTeva- Pharmaceutical Industries Ltd. ADR’s recently made public that its Chief Accounting Officer Weiss Amir unloaded Company’s shares for reported $0.21 ...
Top law firms in US opioid lawsuits to get hundreds of millions in fees By Reuters
Investing.com· 3 hours agoThe panel gave national firm Motley Rice the largest share, with 18.6% of the funds, or $396...
Baltimore City wins $45M settlement with Allergan, seeks billions in suits vs. other opioid...
Baltimore Sun via Yahoo News· 3 hours agoBaltimore went its own way and has won the first leg of a potentially billion-dollar lawsuit against opioid distributors. Pharmaceutical company Allergan will pay the city ...
UIPATH INVESTIGATION ALERT: UiPath, Inc. (NYSE: PATH) Investors Who Suffered Losses from 34% Stock...
Morningstar· 5 days agoNEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into UiPath, Inc. (NYSE: PATH) for potential violations of the federal securities laws after the CEO resigned and the stock
BIOGEN CASE DEADLINE: Biogen Inc. (Nasdaq: BIIB) Investors are Reminded of Upcoming July 2024 Legal...
Benzinga· 2 days agoNEW YORK, June 08, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (NASDAQ:BIIB) Securities Class Action Lawsuit. If you
Exploring High Insider Ownership Growth Stocks On Euronext Paris
Simply Wall St. via Yahoo Finance· 9 hours agoAmid a backdrop of cautious optimism in European markets, with France's CAC 40 Index showing modest...